Koninklijke Philips N.V. (ETR:PHI1)
Germany · Delayed Price · Currency is EUR | Market Cap | 23.10B |
| Revenue (ttm) | 17.78B |
| Net Income (ttm) | 165.00M |
| Shares Out | n/a |
| EPS (ttm) | 0.18 |
| PE Ratio | 140.00 |
| Forward PE | 15.45 |
| Dividend | 0.85 (3.51%) |
| Ex-Dividend Date | May 14, 2025 |
| Volume | 3,492 |
| Average Volume | 10,059 |
| Open | 24.58 |
| Previous Close | 24.42 |
| Day's Range | 24.22 - 24.58 |
| 52-Week Range | 19.13 - 27.59 |
| Beta | 0.84 |
| RSI | 51.97 |
| Earnings Date | Nov 4, 2025 |
About Koninklijke Philips
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides diagnostic imaging solutions, includes magnetic resonance imaging; X-ray systems; and computed tomography (CT) systems and software comprising detector-based spectral CT solutions; ultrasound imaging solutions focused on diagnosis, treatment planning and guidance for cardiac, general imaging, obstetrics/gynecology, ... [Read more]
Financial Performance
In 2024, Koninklijke Philips's revenue was 18.02 billion, a decrease of -0.81% compared to the previous year's 18.17 billion. Losses were -702.00 million, 50.6% more than in 2023.
Financial StatementsNews
Masimo raises EPS guidance to $5.40–$5.55 while advancing AI-enabled monitoring and Philips partnership
Discover key insights from Masimo’s Q3 2025 earnings: strong revenue, margin expansion, and growth in AI monitoring/Philips partnership.
PHG Shares Rise Despite Posting Flat Y/Y Earnings & Revenue Dip in Q3
Philips' third-quarter 2025 earnings remain steady as revenues dip, but segment-wide growth and cost savings lift shares higher.
Philips lays off 33 employees at Seattle-area healthcare device manufacturing facility
Philips Ultrasound is laying off 33 employees from its Bothell, Wash.
Koninklijke Philips NV (PHG) Q3 2025 Earnings Call Highlights: Strong Personal Health Sales and ...
Koninklijke Philips NV (PHG) Q3 2025 Earnings Call Highlights: Strong Personal Health Sales and Margin Expansion Amid Regulatory Challenges
Philips Navigates Tariffs Through Cost Discipline, Reaffirms Outlook
On Tuesday, Koninklijke Philips NV (NYSE: PHG) reported third-quarter 2025 adjusted earnings per share of 42 cents (or 0.36 euros), beating the consensus of 37 cents . The Dutch healthcare technology...
Koninklijke Philips N.V. (PHG) Q3 2025 Earnings Call Transcript
Philips (PHG) Maintains FY25 Financial Targets with Sales and EBITDA Goals
Philips (PHG) Maintains FY25 Financial Targets with Sales and EBITDA Goals
Philips (PHG) Sees Growth in Q3 Revenue and Order Intake
Philips (PHG) Sees Growth in Q3 Revenue and Order Intake
Koninklijke Philips N.V. 2025 Q3 - Results - Earnings Call Presentation
Philips (PHG) Reports Q3 Earnings Beat with Strong Order Growth
Philips (PHG) Reports Q3 Earnings Beat with Strong Order Growth
Philips Expects Full-Year Profitability to Land at Upper-End of Range
Philips reports 3% rise in quarterly sales
Dutch medical technology company Philips reported third-quarter revenue in line with analysts' expectations un Tuesday, citing a strong performance in North America.
Philips Q3 Profit Rises, Sales Down; Sees FY25 Margin Towards Top End Of View
(RTTNews) - Dutch consumer electronics giant Koninklijke Philips N.V. (PHGFF.PK, PHG) reported Tuesday higher profit in its third quarter, despite weak sales. Comparable sales and order intake grew fr...
Philips continues momentum; delivers strong order intake, step-up in sales growth and margin expansion
November 4, 2025 Q3 2025 Group Highlights Comparable order intake growth 8% Group sales amounted to EUR 4.3 billion, reflecting 3% increase in comparable sales Income from operations was EUR 330 milli...
Philips Q3 2025 Earnings Preview
Philips Joins the Forever Promise Project to Honor American Veterans
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its support of the Forever Promise Project, an initiative of the Monument...
Hoag selects Philips to enhance and unify patient monitoring, elevating care across Orange County, USA
October 30, 2025 10-year collaboration aims to connect scalable monitoring technology that streamlines workflows, supporting patient safety and the patient and clinician experience Amsterdam, the Neth...
Longleaf Partners Global Fund Q3 2025 Notable Contributors & Detractors
Our investments are grounded in real assets and brands producing growing free cash flow per share. We believe the Fund's FCF today can go to a mid-teens FCF multiple on growing FCF per share. We belie...
Phia’s founders on how AI is changing online shopping
Phia founders, Phoebe Gates and Sophia Kianni, are building an AI assistant that aims to help you shop, and save.
Philips (PHG) iMODERN Trial Confirms Immediate Artery Treatment Benefits
Philips (PHG) iMODERN Trial Confirms Immediate Artery Treatment Benefits
Late-breaking iMODERN findings presented at TCT 2025 and published in the New England Journal of Medicine highlight new evidence to guide treatment choices for heart attack patients
October 29, 2025 3-Year data from the largest global trial to date using Class I, Level A iFR in heart attack patients shows treating additional stenoses in the same procedure showed no significant di...
Philips Ultrasound Devices Deemed Adulterated Over Manufacturing And Oversight Lapses
The U.S. Food and Drug Administration (FDA) found that devices made at Koninklijke Philips N.V.'s (NYSE:PHG) Bothell, Reedsville, and Nederland facilities were adulterated due to manufacturing, storag...
Philips Ultrasound Devices Deemed Adulterated Over Manufacturing And Oversight Lapses
The U.S. Food and Drug Administration (FDA) found that devices made at Koninklijke Philips N.V. 's (NYSE: PHG) Bothell, Reedsville, and Nederland facilities were adulterated due to manufacturing, sto...
Philips (PHG) Shares Dip Following FDA Compliance Warning
Philips (PHG) Shares Dip Following FDA Compliance Warning